Market Capitalization of GlaxoSmithKline Pharmaceuticals (GLAXO)
As of May 27, 2026, GlaxoSmithKline Pharmaceuticals (GLAXO) market capitalisation is ₹38899.01 Cr ($4.32B), with 16.94 Cr shares outstanding at a current price of ₹2296.20 on NSE, ranking 229 out of 5361 companies by market cap in our screener. GlaxoSmithKline Pharmaceuticals operates in the Healthcare sector and is classified as a Large Cap stock. For live price, earnings and the complete company profile, see GlaxoSmithKline Pharmaceutical stock price NSE.
Market Cap History of GlaxoSmithKline Pharmaceuticals (Last 10 Years)
GLAXO market capitalisation from year-end NSE closing prices over the last 10 years. Analyse GLAXO shareholding pattern to track promoter, FII and institutional holdings.
End of Year Market Cap History — GlaxoSmithKline Pharmaceuticals
GLAXO year-end market cap in INR and USD with closing share price and annual change — NSE closing prices. Read GlaxoSmithKline Pharmaceutical dividend payments for the complete payout history and dividend yield track record.
| Year | Market Cap | Share Price | Exchange | Change |
|---|---|---|---|---|
| 2026 |
₹38899.01 Cr
$4.32B USD
|
₹2296.20 | NSE | -7.17% |
| 2025 |
₹41904.27 Cr
$4.66B USD
|
₹2473.60 | NSE | +9.85% |
| 2024 |
₹38147.69 Cr
$4.24B USD
|
₹2251.85 | NSE | +18.63% |
| 2023 |
₹32155.80 Cr
$3.57B USD
|
₹1898.15 | NSE | +43.94% |
| 2022 |
₹22340.42 Cr
$2.48B USD
|
₹1318.75 | NSE | -24.93% |
| 2021 |
₹29758.71 Cr
$3.31B USD
|
₹1756.65 | NSE | +8.17% |
| 2020 |
₹27510.69 Cr
$3.06B USD
|
₹1623.95 | NSE | +0.85% |
| 2019 |
₹27279.45 Cr
$3.03B USD
|
₹1610.30 | NSE | +6.27% |
| 2018 |
₹25670.94 Cr
$2.85B USD
|
₹1515.35 | NSE | +21.75% |
| 2017 |
₹21085.12 Cr
$2.34B USD
|
₹1244.65 | NSE | -8.81% |
| 2016 |
₹23122.23 Cr
$2.57B USD
|
₹1364.90 | NSE | -17.63% |
| 2015 |
₹28071.09 Cr
$3.12B USD
|
₹1657.03 | NSE | +3.61% |
| 2014 |
₹27091.92 Cr
$3.01B USD
|
₹1599.23 | NSE | +6.68% |
| 2013 |
₹25396.50 Cr
$2.82B USD
|
₹1499.15 | NSE | +38.29% |
| 2012 |
₹18364.12 Cr
$2.04B USD
|
₹1084.03 | NSE | +11.46% |
| 2011 |
₹16476.09 Cr
$1.83B USD
|
₹972.58 | NSE | -16.78% |
| 2010 |
₹19799.33 Cr
$2.20B USD
|
₹1168.75 | NSE | +45.01% |
| 2009 |
₹13653.79 Cr
$1.52B USD
|
₹805.98 | NSE | +40.09% |
| 2008 |
₹9746.44 Cr
$1.08B USD
|
₹575.33 | NSE | +12.02% |
| 2007 |
₹8700.69 Cr
$966.74M USD
|
₹513.60 | NSE | -11.67% |
| 2006 |
₹9850.62 Cr
$1.09B USD
|
₹581.48 | NSE | +3.67% |
| 2005 |
₹9501.64 Cr
$1.06B USD
|
₹560.88 | NSE | +45.67% |
| 2004 |
₹6522.64 Cr
$724.74M USD
|
₹385.03 | NSE | +34.30% |
| 2003 |
₹4856.87 Cr
$539.65M USD
|
₹286.70 | NSE | - |